Yingna He

Dr. Yingna He

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Acta Biomaterialia
Verified
Journal Article
Closed access
HAHeng An
Heng An
YYYan Yang
Yan Yang
ZZZiwei Zhou
Ziwei Zhou
YBYunyi Bo
Yunyi Bo
YWYong Wang
Yong Wang
JQJianglei Qin
Jianglei Qin

1 August 2014 in International Journal of Nanomedicine
Verified
Journal Article
Open access
YHYingna He
Yingna He
LZLinhua Zhang
Linhua Zhang
CSCunxian Song
Cunxian Song
DZDunwan Zhu
Dunwan Zhu
Tumor-targeting multifunctional liposomes simultaneously loaded with magnetic iron oxide nanoparticles (MIONs) as a magnetic resonance imaging (MRI) contrast agent and anticancer drug, mitoxantrone (Mit), were developed for targeted cancer therapy and ultrasensitive MRI. The gonadorelin-functionalized MION/Mit-loaded liposome (Mit-GML) showed significantly increased uptake in luteinizing hormone–releasing hormone (LHRH) receptor overexpressing MCF-7 (Michigan Cancer Foundation-7) breast cancer cells over a gonadorelin-free MION/Mit-loaded liposome (Mit-ML) control, as well as in an LHRH receptor low-expressing Sloan-Kettering HER2 3+ Ovarian Cancer (SK-OV-3) cell control, thereby leading to high cytotoxicity against the MCF-7 human breast tumor cell line. The Mit-GML formulation was more effective and less toxic than equimolar doses of free Mit or Mit-ML in the treatment of LHRH receptors overexpressing MCF-7 breast cancer xenografts in mice. Furthermore, the Mit-GML demonstrated much higher T2 enhancement than did Mit-ML controls in vivo. Collectively, the study indicates that the integrated diagnostic and therapeutic design of Mit-GML nanomedicine potentially allows for the image-guided, target-specific treatment of cancer.

28 June 2024 in Phytomedicine
Verified
Journal Article
Closed access
CJCui-Ling Jia
Cui-Ling Jia
YGYujing Gou
Yujing Gou
YGYuhui Gao
Yuhui Gao
XPXiaocui Pei
Xiaocui Pei
XJXiaofei Jin
Xiaofei Jin
YZYashuo Zhao
Yashuo Zhao

11 October 2021 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
YBYunyi Bo
Yunyi Bo
LZLinhua Zhang
Linhua Zhang
ZWZhifeng Wang
Zhifeng Wang
JSJiafu Shen
Jiafu Shen
ZZZiwei Zhou
Ziwei Zhou
YHYingna He
Yingna He

1 November 2019 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
FHFangjie Hou
Fangjie Hou
BXBaozhong Xi
Baozhong Xi
XWXuemeng Wang
Xuemeng Wang
YYYan Yang
Yan Yang
HZHaifeng Zhao
Haifeng Zhao
YHYingna He
Yingna He

1 April 2021 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
JSJiafu Shen
Jiafu Shen
ZZZiwei Zhou
Ziwei Zhou
DCDanyang Chen
Danyang Chen
YWYong Wang
Yong Wang
YHYingna He
Yingna He
JQJianglei Qin
Jianglei Qin